Patents by Inventor Michael Jarpe

Michael Jarpe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INITIATING NEUROTOXIN TREATMENTS
    Publication number: 20230058666
    Abstract: Disclosed herein are compositions and methods for use in initiating neurotoxin treatments.
    Type: Application
    Filed: April 20, 2022
    Publication date: February 23, 2023
    Inventors: Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20230027850
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures.
    Type: Application
    Filed: February 28, 2022
    Publication date: January 26, 2023
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS PRODUCTION METHODS
    Publication number: 20230016041
    Abstract: Disclosed herein are systems and methods for manufacturing botulinum neurotoxin serotype E (BoNT/E) with improved yield and purity of BoNT/E. Disclosed herein are systems and methods for manufacturing BoNT/E drug substance.
    Type: Application
    Filed: February 28, 2022
    Publication date: January 19, 2023
    Inventors: Satish Menon, Michael Jarpe, Kenton Able
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20220395561
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: March 30, 2022
    Publication date: December 15, 2022
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • SMART HEAD COOLING SYSTEM
    Publication number: 20220378605
    Abstract: A headpiece includes a shell, a thermoelectric cooler, a heat sink and a fan. The shell defines a concavity. The thermoelectric cooler includes a cooling surface and a warming surface. The heat sink is in thermal communication with the warming surface. The fan is in fluid communication with the heat sink.
    Type: Application
    Filed: August 8, 2022
    Publication date: December 1, 2022
    Inventors: Sawsan (Susan) Abushakra, Michael A. Jarpe, Orlando P. Rodrigues
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20220370574
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: March 23, 2022
    Publication date: November 24, 2022
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN INHIBITING CGRP
    Publication number: 20220306704
    Abstract: Disclosed herein are compositions and methods for use in inhibiting CGRP production and release.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 29, 2022
    Inventors: Michael Jarpe, Fauad Hasan
  • Botulinum neurotoxins for use in therapy
    Patent number: 11260114
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: March 1, 2022
    Assignee: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE
    Publication number: 20210145955
    Abstract: Disclosed herein are compositions and methods for use in neurotoxin treatments.
    Type: Application
    Filed: June 26, 2018
    Publication date: May 20, 2021
    Inventors: Kenton Abel, Michael Jarpe, Fauad Hasan
  • BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
    Publication number: 20210106660
    Abstract: Disclosed herein are compositions and methods for use in treating hyperhidrosis.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 15, 2021
    Inventors: Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS PRODUCTION METHODS
    Publication number: 20210108187
    Abstract: Disclosed herein are systems and methods for manufacturing botulinum neurotoxin serotype E (BoNT/E) with improved yield and purity of BoNT/E. Disclosed herein are systems and methods for manufacturing BoNT/E drug substance.
    Type: Application
    Filed: April 27, 2018
    Publication date: April 15, 2021
    Inventors: Satish Menon, Michael Jarpe, Kenton Able
  • BOTULINUM NEUROTOXINS FOR USE IN THERAPY
    Publication number: 20200046814
    Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
    Type: Application
    Filed: March 22, 2018
    Publication date: February 13, 2020
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • INITIATING NEUROTOXIN TREATMENTS
    Publication number: 20200038492
    Abstract: Disclosed herein are compositions and methods for use in initiating neurotoxin treatments.
    Type: Application
    Filed: April 20, 2018
    Publication date: February 6, 2020
    Inventors: Fauad Hasan, Michael Jarpe
  • BOTULINUM NEUROTOXINS FOR TREATING TRAUMATIC INJURIES
    Publication number: 20200023044
    Abstract: Disclosed herein are compositions and methods for use in treating injuries.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 23, 2020
    Applicant: Bonti, Inc.
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • NEUROTOXINS FOR USE IN INHIBITING CGRP
    Publication number: 20190300583
    Abstract: Disclosed herein are compositions and methods for use in inhibiting CGRP production and release.
    Type: Application
    Filed: April 3, 2019
    Publication date: October 3, 2019
    Inventors: Michael Jarpe, Fauad Hasan
  • NEUROTOXINS FOR USE IN MINIMIZING SCARRING
    Publication number: 20190183987
    Abstract: Methods to minimize scarring during the wound healing process are described. Methods to improve appearance of a scar that forms over a wound are also described. The methods comprise administering a therapeutically effective amount of botulinum toxin subtype E (BoNT/E) in the proximity of a wound.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
  • Methods for treating neurological injuries and disorders
    Patent number: 6872698
    Abstract: The present invention relates to methods for treatment of nerve cell death (degeneration) and neurodegenerative diseases. Methods of the invention include administering, an effective amount of GDF-1 alone or in combination with neurotrophin-3, to a patient in need of such treatment such as a person suffering from stroke or traumatic brain injury or a neurodegenerative disease.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: March 29, 2005
    Assignee: Scion Pharmaceuticals, Inc.
    Inventors: Mark Marchionni, Michael Jarpe, Ted Ebendal
  • Methods for treating neurological injuries and disorders
    Publication number: 20030069176
    Abstract: The present invention relates to methods for treatment of nerve cell death (degeneration) and neurodegenerative diseases. Methods of the invention include administering, an effective amount of GDF-1 alone or in combination with neurotrophin-3, to a patient in need of such treatment such as a person suffering from stroke or traumatic brain injury or a neurodegenerative disease.
    Type: Application
    Filed: January 8, 2001
    Publication date: April 10, 2003
    Applicant: Cambridge NeuroScience, Inc.
    Inventors: Mark Marchionni, Michael Jarpe, Ted Ebendal